This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kristal-Boneh, E. Articles by Ribak, J. Search for Related Content PubMed PubMed Citation Articles by Kristal-Boneh, E. Articles by Ribak, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB 1,25-DIHYDROXYCHOLECALCIFEROL

(Hypertension. 1997;30:1289-1294.)
© 1997 American Heart Association, Inc.

Articles

Association of Calcitriol and Blood Pressure in Normotensive Men

Estela Kristal-Boneh; Paul Froom; Gil Harari; Joseph Ribak

From the Occupational Health and Rehabilitation Institute (E.K.-B., P.F., G.H., J.R.), Raanana, and the Sackler Faculty of Medicine (P.F., J.R.), Tel Aviv University, Tel Aviv, Israel.

Correspondence to Dr E. Kristal-Boneh, Occupational Health and Rehabilitation Institute, POB 3, Raanana 43100, Israel.

Abstract The purpose of this study was to clarify the possible associations between the serum 1,25-dihydroxyvitamin D (calcitriol) level and blood pressure. Cross-sectional analysis of data was performed. Data collected included levels of serum calcitriol, parathyroid hormone, serum calcium, and blood lead; blood pressure; dietary history; and demographic and anthropometric variables. One hundred normotensive male industrial employees made up the study population. Systolic blood pressure and diastolic blood pressure were main outcome measures. After possible confounders were controlled for, multivariate analyses yielded an inverse, independent, and statistically significant association between calcitriol level and systolic blood pressure (standardized ß=-0.2704, P=.0051). A similar trend of borderline significance was found for the association between calcitriol and diastolic blood pressure (standardized ß=-0.1814, P=.0611). Parathyroid hormone, serum calcium, and blood lead levels were not associated with blood pressure. When subjects were divided into four groups by calcitriol level, those in the lowest quartile showed significantly higher systolic and diastolic blood pressures than those in the upper quartile (difference=11 mm Hg, P=.007, and difference=4 mm Hg, P=.071, respectively). There is an inverse association between serum calcitriol level and blood pressure. This suggests that in addition to its role in calcium homeostasis, the active metabolite of vitamin D may play a role in determining blood pressure. The differences in both systolic and diastolic blood pressures between the upper and lower quartiles of serum calcitriol were substantial and may be of clinical significance.

Key Words: vitamin D • blood pressure • lead

This article has been cited by other articles:

				J. M. Valdivielso, J. Cannata-Andia, B. Coll, and E. Fernandez A new role for vitamin D receptor activation in chronic kidney disease Am J Physiol Renal Physiol, December 1, 2009; 297(6): F1502 - F1509. [Abstract] [Full Text] [PDF]

				C.-C. Szeto and P. K.-T. Li The use of vitamin D analogues in chronic kidney diseases: possible mechanisms beyond bone and mineral metabolism NDT Plus, June 1, 2009; 2(3): 205 - 212. [Abstract] [Full Text] [PDF]

				P. J. Matias, C. Ferreira, C. Jorge, M. Borges, I. Aires, T. Amaral, C. Gil, J. Cortez, and A. Ferreira 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients Nephrol. Dial. Transplant., February 1, 2009; 24(2): 611 - 618. [Abstract] [Full Text] [PDF]

				K. L. Adeney, D. S. Siscovick, J. H. Ix, S. L. Seliger, M. G. Shlipak, N. S. Jenny, and B. R. Kestenbaum Association of Serum Phosphate with Vascular and Valvular Calcification in Moderate CKD J. Am. Soc. Nephrol., February 1, 2009; 20(2): 381 - 387. [Full Text] [PDF]

				R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice Endocr. Rev., October 1, 2008; 29(6): 726 - 776. [Abstract] [Full Text] [PDF]

				D. E. Wallis, S. Penckofer, and G. W. Sizemore The "Sunshine Deficit" and Cardiovascular Disease Circulation, September 30, 2008; 118(14): 1476 - 1485. [Full Text] [PDF]

				P. Alborzi, N. A. Patel, C. Peterson, J. E. Bills, D. M. Bekele, Z. Bunaye, R. P. Light, and R. Agarwal Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease: A Randomized Double-Blind Pilot Trial Hypertension, August 1, 2008; 52(2): 249 - 255. [Abstract] [Full Text] [PDF]

				M. S. K. Wong, R. Delansorne, R. Y. K. Man, and P. M. Vanhoutte Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H289 - H296. [Abstract] [Full Text] [PDF]

				T. J. Wang, M. J. Pencina, S. L. Booth, P. F. Jacques, E. Ingelsson, K. Lanier, E. J. Benjamin, R. B. D'Agostino, M. Wolf, and R. S. Vasan Vitamin D Deficiency and Risk of Cardiovascular Disease Circulation, January 29, 2008; 117(4): 503 - 511. [Abstract] [Full Text] [PDF]

				G. M. London, A. P. Guerin, F. H. Verbeke, B. Pannier, P. Boutouyrie, S. J. Marchais, and F. Metivier Mineral Metabolism and Arterial Functions in End-Stage Renal Disease: Potential Role of 25-Hydroxyvitamin D Deficiency J. Am. Soc. Nephrol., February 1, 2007; 18(2): 613 - 620. [Abstract] [Full Text] [PDF]

				J. P. Forman, H. A. Bischoff-Ferrari, W. C. Willett, M. J. Stampfer, and G. C. Curhan Vitamin D Intake and Risk of Incident Hypertension: Results From Three Large Prospective Cohort Studies Hypertension, October 1, 2005; 46(4): 676 - 682. [Abstract] [Full Text] [PDF]

				M. Teng, M. Wolf, M. N. Ofsthun, J. M. Lazarus, M. A. Hernan, C. A. Camargo Jr, and R. Thadhani Activated Injectable Vitamin D and Hemodialysis Survival: A Historical Cohort Study J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1115 - 1125. [Abstract] [Full Text] [PDF]

				P.E. Norman and J.T. Powell Vitamin D, Shedding Light on the Development of Disease in Peripheral Arteries Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 39 - 46. [Abstract] [Full Text] [PDF]

				J. Kong and Y. C. Li Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R255 - R261. [Abstract] [Full Text] [PDF]

				A. L. M. Sutton and P. N. MacDonald Vitamin D: More Than a "Bone-a-Fide" Hormone Mol. Endocrinol., May 1, 2003; 17(5): 777 - 791. [Abstract] [Full Text] [PDF]

				M. Pfeifer, B. Begerow, H. W. Minne, D. Nachtigall, and C. Hansen Effects of a Short-Term Vitamin D3 and Calcium Supplementation on Blood Pressure and Parathyroid Hormone Levels in Elderly Women J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1633 - 1637. [Abstract] [Full Text]